+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Male Infertility Market By Treatment, By Test, By Region, Industry Analysis and Forecast, 2020 - 2026

  • PDF Icon

    Report

  • 173 Pages
  • June 2020
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5129403
Description Jump to:
The Global Male Infertility Market size is expected to reach $3.2 billion by 2026, rising at a market growth of 7.6% CAGR during the forecast period. Male infertility is the inability of a male to cause pregnancy in a fertile female. A male's fertility relies mainly on the quantity and quality of their sperms. If a man's sperm count is small or if the sperm is of poor quality, it is expected to be difficult, and even impossible, for him to cause pregnancy. The problem of infertility is widespread. Male fertility includes the normal functioning of the hypothalamus, pituitary gland, and testes. Nonetheless, 40 percent-50 percent of cases have no identifiable cause and 30 percent-40 percent of cases are due to problems in the testes.

Continuous R&D efforts are being made to better understand the idiopathic world of infertility. As a result, companies are investing in the development of root cause identification and targeted treatment devices. In addition, the production and commercialization of hormonal therapy are expected to fuel the demand for male infertility during the forecast period. Governments in different countries have taken steps to boost the recovery scenario for infertility-related therapies. In addition, improved safety of patient data due to standardization of legislation is expected to increase consumer demand for infertility treatment.

Advancements in medical testing and rising infertility in males are two of the main factors driving the demand for male infertility. In addition, lifestyle-associated disorders causing infertility, rising obesity, and the expanding aging population are likely to boost the market growth over the forecast period. In the U.S., one-third of cases of infertility are attributed to female factors, one third to male causes, and the other one third is uncertain.

ARTs are used to cure major factors responsible for male infertility. These factors range from sperm autoantibodies, viral orchitis, epididymal dysfunction, accessory gland infections, chemotherapy, to heat, trauma, and other idiopathic factors. High treatment costs and the requirement for several other treatment cycles are some of the key factors contributing to the growth of the segment. Growing spending on health care in developed countries, raising awareness of male infertility, and growing acceptance in middle and low-income countries are the main factors projected to drive the ART segment over the forecast period.

Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.

Scope of the Study

Market Segmentation:

By Treatment
  • Assisted Reproductive Technology & Varicocele Surgery and
  • Medication

By Tests
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Sperm Penetration Assay and
  • Other Tests

By Geography

North America
  • US
  • Canada
  • Mexico
  • Rest of North America

Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Sanofi S.A.
  • Bayer AG
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Endo International PLC
  • Aytu BioScience, Inc.
  • Vitrolife AB
  • SCSA Diagnostics, Inc.
  • Andrology Solutions Limited
  • Halotech DNA SL
  • Intas Pharmaceutical Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Male Infertility Market, by Treatment
1.4.2 Global Male Infertility Market, by Tests
1.4.3 Global Male Infertility Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Male Infertility Market by Treatment
3.1 Global Assisted Reproductive Technology and Varicocele Surgery Market by Region
3.2 Global Medication Market by Region
Chapter 4. Global Male Infertility Market by Test
4.1 Global DNA Fragmentation Technique Market by Region
4.2 Global Oxidative Stress Analysis Market by Region
4.3 Global Computer Assisted Semen Analysis Market by Region
4.4 Global Microscopic Examination Market by Region
4.5 Global Sperm Agglutination Market by Region
4.6 Global Sperm Penetration Assay Market by Region
4.7 Global Other Test Market by Region
Chapter 5. Global Male Infertility Market by Region
5.1 North America Male Infertility Market
5.1.1 North America Male Infertility Market by Treatment
5.1.1.1 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.1.1.2 North America Medication Market by Country
5.1.2 North America Male Infertility Market by Test
5.1.2.1 North America DNA Fragmentation Technique Market by Country
5.1.2.2 North America Oxidative Stress Analysis Market by Country
5.1.2.3 North America Computer Assisted Semen Analysis Market by Country
5.1.2.4 North America Microscopic Examination Market by Country
5.1.2.5 North America Sperm Agglutination Market by Country
5.1.2.6 North America Sperm Penetration Assay Market by Country
5.1.2.7 North America Other Test Market by Country
5.1.3 North America Male Infertility Market by Country
5.1.3.1 US Male Infertility Market
5.1.3.1.1 US Male Infertility Market by Treatment
5.1.3.1.2 US Male Infertility Market by Test
5.1.3.2 Canada Male Infertility Market
5.1.3.2.1 Canada Male Infertility Market by Treatment
5.1.3.2.2 Canada Male Infertility Market by Test
5.1.3.3 Mexico Male Infertility Market
5.1.3.3.1 Mexico Male Infertility Market by Treatment
5.1.3.3.2 Mexico Male Infertility Market by Test
5.1.3.4 Rest of North America Male Infertility Market
5.1.3.4.1 Rest of North America Male Infertility Market by Treatment
5.1.3.4.2 Rest of North America Male Infertility Market by Test
5.2 Europe Male Infertility Market
5.2.1 Europe Male Infertility Market by Treatment
5.2.1.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.2.1.2 Europe Medication Market by Country
5.2.2 Europe Male Infertility Market by Test
5.2.2.1 Europe DNA Fragmentation Technique Market by Country
5.2.2.2 Europe Oxidative Stress Analysis Market by Country
5.2.2.3 Europe Computer Assisted Semen Analysis Market by Country
5.2.2.4 Europe Microscopic Examination Market by Country
5.2.2.5 Europe Sperm Agglutination Market by Country
5.2.2.6 Europe Sperm Penetration Assay Market by Country
5.2.2.7 Europe Other Test Market by Country
5.2.3 Europe Male Infertility Market by Country
5.2.3.1 Germany Male Infertility Market
5.2.3.1.1 Germany Male Infertility Market by Treatment
5.2.3.1.2 Germany Male Infertility Market by Test
5.2.3.2 UK Male Infertility Market
5.2.3.2.1 UK Male Infertility Market by Treatment
5.2.3.2.2 UK Male Infertility Market by Test
5.2.3.3 France Male Infertility Market
5.2.3.3.1 France Male Infertility Market by Treatment
5.2.3.3.2 France Male Infertility Market by Test
5.2.3.4 Russia Male Infertility Market
5.2.3.4.1 Russia Male Infertility Market by Treatment
5.2.3.4.2 Russia Male Infertility Market by Test
5.2.3.5 Spain Male Infertility Market
5.2.3.5.1 Spain Male Infertility Market by Treatment
5.2.3.5.2 Spain Male Infertility Market by Test
5.2.3.6 Italy Male Infertility Market
5.2.3.6.1 Italy Male Infertility Market by Treatment
5.2.3.6.2 Italy Male Infertility Market by Test
5.2.3.7 Rest of Europe Male Infertility Market
5.2.3.7.1 Rest of Europe Male Infertility Market by Treatment
5.2.3.7.2 Rest of Europe Male Infertility Market by Test
5.3 Asia Pacific Male Infertility Market
5.3.1 Asia Pacific Male Infertility Market by Treatment
5.3.1.1 Asia Pacific Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.3.1.2 Asia Pacific Medication Market by Country
5.3.2 Asia Pacific Male Infertility Market by Test
5.3.2.1 Asia Pacific DNA Fragmentation Technique Market by Country
5.3.2.2 Asia Pacific Oxidative Stress Analysis Market by Country
5.3.2.3 Asia Pacific Computer Assisted Semen Analysis Market by Country
5.3.2.4 Asia Pacific Microscopic Examination Market by Country
5.3.2.5 Asia Pacific Sperm Agglutination Market by Country
5.3.2.6 Asia Pacific Sperm Penetration Assay Market by Country
5.3.2.7 Asia Pacific Other Test Market by Country
5.3.3 Asia Pacific Male Infertility Market by Country
5.3.3.1 India Male Infertility Market
5.3.3.1.1 India Male Infertility Market by Treatment
5.3.3.1.2 India Male Infertility Market by Test
5.3.3.2 China Male Infertility Market
5.3.3.2.1 China Male Infertility Market by Treatment
5.3.3.2.2 China Male Infertility Market by Test
5.3.3.3 Japan Male Infertility Market
5.3.3.3.1 Japan Male Infertility Market by Treatment
5.3.3.3.2 Japan Male Infertility Market by Test
5.3.3.4 South Korea Male Infertility Market
5.3.3.4.1 South Korea Male Infertility Market by Treatment
5.3.3.4.2 South Korea Male Infertility Market by Test
5.3.3.5 Singapore Male Infertility Market
5.3.3.5.1 Singapore Male Infertility Market by Treatment
5.3.3.5.2 Singapore Male Infertility Market by Test
5.3.3.6 Malaysia Male Infertility Market
5.3.3.6.1 Malaysia Male Infertility Market by Treatment
5.3.3.6.2 Malaysia Male Infertility Market by Test
5.3.3.7 Rest of Asia Pacific Male Infertility Market
5.3.3.7.1 Rest of Asia Pacific Male Infertility Market by Treatment
5.3.3.7.2 Rest of Asia Pacific Male Infertility Market by Test
5.4 LAMEA Male Infertility Market
5.4.1 LAMEA Male Infertility Market by Treatment
5.4.1.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.4.1.2 LAMEA Medication Market by Country
5.4.2 LAMEA Male Infertility Market by Test
5.4.2.1 LAMEA DNA Fragmentation Technique Market by Country
5.4.2.2 LAMEA Oxidative Stress Analysis Market by Country
5.4.2.3 LAMEA Computer Assisted Semen Analysis Market by Country
5.4.2.4 LAMEA Microscopic Examination Market by Country
5.4.2.5 LAMEA Sperm Agglutination Market by Country
5.4.2.6 LAMEA Sperm Penetration Assay Market by Country
5.4.2.7 LAMEA Other Test Market by Country
5.4.3 LAMEA Male Infertility Market by Country
5.4.3.1 Brazil Male Infertility Market
5.4.3.1.1 Brazil Male Infertility Market by Treatment
5.4.3.1.2 Brazil Male Infertility Market by Test
5.4.3.2 Argentina Male Infertility Market
5.4.3.2.1 Argentina Male Infertility Market by Treatment
5.4.3.2.2 Argentina Male Infertility Market by Test
5.4.3.3 UAE Male Infertility Market
5.4.3.3.1 UAE Male Infertility Market by Treatment
5.4.3.3.2 UAE Male Infertility Market by Test
5.4.3.4 Saudi Arabia Male Infertility Market
5.4.3.4.1 Saudi Arabia Male Infertility Market by Treatment
5.4.3.4.2 Saudi Arabia Male Infertility Market by Test
5.4.3.5 South Africa Male Infertility Market
5.4.3.5.1 South Africa Male Infertility Market by Treatment
5.4.3.5.2 South Africa Male Infertility Market by Test
5.4.3.6 Nigeria Male Infertility Market
5.4.3.6.1 Nigeria Male Infertility Market by Treatment
5.4.3.6.2 Nigeria Male Infertility Market by Test
5.4.3.7 Rest of LAMEA Male Infertility Market
5.4.3.7.1 Rest of LAMEA Male Infertility Market by Treatment
5.4.3.7.2 Rest of LAMEA Male Infertility Market by Test
Chapter 6. Company Profiles
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.10 Intas Pharmaceutical Ltd.
6.10.1 Company Overview

Companies Mentioned

  • Sanofi S.A.
  • Bayer AG
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Endo International PLC
  • Aytu BioScience, Inc.
  • Vitrolife AB
  • SCSA Diagnostics, Inc.
  • Andrology Solutions Limited
  • Halotech DNA SL
  • Intas Pharmaceutical Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type, Channel, Services , By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type, Channel, Services , By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 289 Pages
  • Global
From
Global Fertility Services Market Report by Cause of Infertility, Procedure, Service, End-User, and Region 2024-2032 - Product Image

Global Fertility Services Market Report by Cause of Infertility, Procedure, Service, End-User, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2024-2032 - Product Image

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Global Male Infertility Market by Test (Computer-Assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination), Treatment (Assisted Reproductive Technology, Medication) - Forecast 2024-2030 - Product Image

Global Male Infertility Market by Test (Computer-Assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination), Treatment (Assisted Reproductive Technology, Medication) - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Male Infertility - Global Strategic Business Report - Product Image

Male Infertility - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.